Calprotectin: Clinical applications in pediatrics

29Citations
Citations of this article
53Readers
Mendeley users who have this article in their library.
Get full text

Abstract

As seen over the past 20 years, calprotectin has evolved as a novel, non-invasive biomarker of gastrointestinal (GI) inflammation. We present this review of calprotectin in pediatrics. This article will focus on studies using calprotectin concentrations from different body fluids to monitor inflammation in different disease states and conditions. The ultimate goal of our group is to lay down a foundation as we consider using calprotectin prospectively as a marker of intestinal inflammation that could lead to further testing and possibly a marker of preparedness for feeding. We surveyed all published studies in English of calprotectin in neonates, infants, children, and adolescents through February 2014. We will discuss calprotectin’s basic properties and analysis such as characteristics, identification, presence in body fluids, and maturational development. In addition, calprotectin’s use in inflammatory diseases exploring both GI and non-GI conditions will be evaluated and compared with other serum markers presently available. Finally, a summary of our findings and discussion of future work that could be undertaken in order to render calprotectin as a more useful monitoring tool to the medical research community will complete the review.

Cite

CITATION STYLE

APA

Herrera, O. R., Christensen, M. L., & Helms, R. A. (2016, July 1). Calprotectin: Clinical applications in pediatrics. Journal of Pediatric Pharmacology and Therapeutics. Pediatric Pharmacy Advocacy Group, Inc. https://doi.org/10.5863/1551-6776-21.4.308

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free